Allergic Rhinitis - Pipeline Review, H2 2015 Now Available at iData Insights Allergic Rhinitis - Pipeline Review, H2 2015 Summary Global Markets Direct s, Allergic Rhinitis - Pipeline Review, H2 2015, provides an overview of the Allergic Rhinitis s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Rhinitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Allergic Rhinitis - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Allergic Rhinitis and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Allergic Rhinitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Allergic Rhinitis pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Allergic Rhinitis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Allergic Rhinitis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and 1
expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Browse Complete Report with TOC http://www.idatainsights.com/reports-landingpage.php?id=179092/allergic-rhinitis-pipeline-review-h2-2015 To Get Sample Copy of Report visit http://www.idatainsights.com/reports-landingpage.php?id=179092/allergic-rhinitis-pipeline-review-h2-2015 Table of Contents Table of Contents 2 List of Tables 5 List of Figures 7 Introduction 8 Global Markets Direct Report Coverage 8 Allergic Rhinitis Overview 9 Therapeutics Development 10 Pipeline Products for Allergic Rhinitis - Overview 10 Pipeline Products for Allergic Rhinitis - Comparative Analysis 11 Allergic Rhinitis - Therapeutics under Development by Companies 12 Allergic Rhinitis - Therapeutics under Investigation by Universities/Institutes 16 Allergic Rhinitis - Pipeline Products Glance 17 Late Stage Products 17 Clinical Stage Products 18 Early Stage Products 19 Allergic Rhinitis - Products under Development by Companies 20 Allergic Rhinitis - Products under Investigation by Universities/Institutes 25 Allergic Rhinitis - Companies Involved in Therapeutics Development 26 3M Drug Delivery Systems 26 2
3SBio Inc. 27 Accolade Pharma LLC 28 Adamis Pharmaceuticals Corporation 29 AFFiRiS AG 30 ALK-Abello A/S 31 Ampio Pharmaceuticals, Inc. 32 AnaptysBio, Inc. 33 Axikin Pharmaceuticals, Inc. 34 BioTech Tools s.a. 35 Chong Kun Dang Pharmaceutical Corp. 36 ELORAC, Inc. 37 FAES Farma SA 38 Fountain Biopharma Inc. 39 GenMont Biotech Inc. 40 GlaxoSmithKline Plc 41 Glenmark Pharmaceuticals Ltd. 42 GlycoMar Limited 43 HAL Allergy BV 44 Hanmi Pharmaceuticals, Co. Ltd. 45 Hisamitsu Pharmaceutical Co., Inc. 46 Johnson & Johnson 47 Laboratorios LETI S.L. 48 Ligand Pharmaceuticals, Inc. 49 3
Marinomed Biotechnologie GmbH 50 Merck & Co., Inc. 51 Mitsubishi Tanabe Pharma Corporation 52 Nektar Therapeutics 53 NeoPharm Co., Ltd. 54 Novartis AG 55 Nuvo Research Inc. 56 Oxagen Limited 57 Panmira Pharmaceuticals, LLC. 58 Pfizer Inc. 59 Protectimmun GmbH 60 Regeneron Pharmaceuticals, Inc. 61 Revance Therapeutics, Inc. 62 Roxall Medizin GmbH 63 Sanofi 64 Shionogi & Co., Ltd. 65 Stallergenes S.A. 66 VentiRx Pharmaceuticals, Inc. 67 Xencor, Inc. 68 Ziarco Pharma Ltd 69 Allergic Rhinitis - Therapeutics Assessment 70 Assessment by Monotherapy Products 70 Assessment by Combination Products 71 Assessment by Target 72 4
Assessment by Mechanism of Action 74 Assessment by Route of Administration 76 Assessment by Molecule Type 78 Read More http://www.idatainsights.com/reports-landing-page.php?id=179092/allergic-rhinitispipeline-review-h2-2015 About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line. ContactUs: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future project.
5